| Trial name or title |
Novel treatment of phobias in children and teenagers |
| Methods |
Randomised, controlled parallel trial |
| Participants |
Individuals aged 7 to 17 years with a DSM‐IV‐TR diagnosis of any anxiety disorders and specific phobia |
| Interventions |
DCS and exposure therapy versus placebo pill and exposure therapy. Participants receive 1 session of exposure therapy with 35 or 70 mg of DCS (dose dependant on child's weight) at the beginning of the session |
| Outcomes |
Anxiety Disorders Interview Schedule (ADIS), Childrens Global Assessment Scale (CGAS), Fear Survey Schedule for Children Revised, Spence Children's Anxiety Scale |
| Starting date |
March 2012 |
| Contact information |
l.farrell@griffith.edu.au |
| Notes |
Study ID: ACTRN12612000420842 |
